Literature DB >> 23540372

Do different types of financial support after illness or injury affect socio-economic outcomes? A natural experiment in New Zealand.

Susan McAllister1, Sarah Derrett, Rick Audas, Peter Herbison, Charlotte Paul.   

Abstract

BACKGROUND: In New Zealand, people unable to work due to an illness may be eligible for a means-tested benefit whereas injured people are eligible for a wide range of support including earnings-related compensation through the no-fault Accident Compensation Corporation (ACC). The effect of this difference on socio-economic outcomes has not been investigated before.
METHODS: A comparative cohort study was undertaken of stroke versus injury. Individuals aged 18-64, who had a first-stroke (n = 109) were matched by age, sex and functional impairment with injured individuals (n = 429) participating in the Prospective Outcomes of Injury Study. Data were collected by interview 3.5 and 12 months after stroke or injury. Logistic regression adjusting for the matching variables at 3.5 months, and functional impairment at 12 months, was undertaken.
RESULTS: Median personal income declined by 60% over 12 months for the Stroke Group compared to 13% decline in the Injury Group. Decline in income was greater for those in both groups who had a higher income initially, and for those who had not returned to work. The proportion of the Stroke Group reporting 'Fairly low/low' standard of living increased from 8% to 28% and 'Just/not enough' income increased from 35% to 61% whereas the Injury Group increased only from 5% to 12% and 33%-44% respectively. The odds of reporting low standard of living and income inadequacy at 12 months were significantly less for the Injury Group. Despite earnings-related compensation (80% of income), the odds of being back at work were greater for the Injury Group compared to the Stroke Group (Adjusted Odds Ratio 3.1; 95% CI 1.7-5.6).
CONCLUSIONS: These findings support the conclusions that earnings-related compensation and rehabilitative support, available to injured people via ACC, largely prevents the downward spiral into poverty and ill health. It also appears to enhance return to work though residual confounding cannot be ruled out.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23540372     DOI: 10.1016/j.socscimed.2013.02.041

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  [Long-term outcome following multiple trauma in working age : A prospective study in a Swiss trauma center].

Authors:  T Gross; F Amsler
Journal:  Unfallchirurg       Date:  2016-11       Impact factor: 1.000

2.  Impact of further injury on participation in work and activities among those previously injured: results from a New Zealand prospective cohort study.

Authors:  Suzanne J Wilson; Gabrielle Davie; Helen Harcombe; Emma H Wyeth; Ian D Cameron; Sarah Derrett
Journal:  Qual Life Res       Date:  2018-08-21       Impact factor: 4.147

3.  Does injury claim status and benefit status predict low back pain outcomes?

Authors:  Markus Melloh; Jon Cornwall; Rebecca J Crawford; Achim Elfering
Journal:  Australas Med J       Date:  2015-08-31

4.  Longitudinal depressive and anxiety symptoms of adult injury patients in Kenya and their risk factors.

Authors:  Yuen W Hung; Rashelle Musci; Wietse Tol; Stephanie Aketch; Abdulgafoor M Bachani
Journal:  Disabil Rehabil       Date:  2019-05-12       Impact factor: 3.033

5.  Compensation Research Database: population-based injury data for surveillance, linkage and mining.

Authors:  Khic-Houy Prang; Behrooz Hassani-Mahmooei; Alex Collie
Journal:  BMC Res Notes       Date:  2016-10-01

6.  Return to work after ischemic stroke in young adults: A registry-based follow-up study.

Authors:  Karoliina Aarnio; Jorge Rodríguez-Pardo; Bob Siegerink; Juliane Hardt; Jenna Broman; Lauri Tulkki; Elena Haapaniemi; Markku Kaste; Turgut Tatlisumak; Jukka Putaala
Journal:  Neurology       Date:  2018-10-12       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.